[HTML][HTML] Lipids and lipoproteins in health and disease: focus on targeting atherosclerosis
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - Biomedicines, 2021 - mdpi.com
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - 2021 - agris.fao.org
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis.
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - Biomedicines, 2021 - europepmc.org
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis.
CK Lee, CW Liao, SW Meng, WK Wu… - …, 2021 - search.ebscohost.com
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
L Chih-Kuo, L Che-Wei, M Shih-Wei, W Wei-Kai… - …, 2021 - search.proquest.com
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
[PDF][PDF] Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis. Biomedicines 2021, 9, 985
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - 2021 - pdfs.semanticscholar.org
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
CK Lee, CW Liao, SW Meng, WK Wu… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
[HTML][HTML] Lipids and Lipoproteins in Health and Disease: Focus on Targeting Atherosclerosis
CK Lee, CW Liao, SW Meng, WK Wu, JY Chiang… - …, 2021 - ncbi.nlm.nih.gov
Despite advances in pharmacotherapy, intervention devices and techniques, residual
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …
cardiovascular risks still cause a large burden on public health. Whilst most guidelines …